Norway· NO-ID_FA154D08-2FCB-4CDB-A11E-5999F61E9BA8
Microlax
A natriumlaurylsulfoacetat, inkl. kombinationen product containing sodium citrate + sorbitol + sodium lauryl sulfoacetate, registered in Norway by McNeil Sweden AB. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Natriumlaurylsulfoacetat, inkl. kombinationen is registered in 9 of 19 countries.
Countries holding a registration under ATC A06AG11 (natriumlaurylsulfoacetat, inkl. kombinationen), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Natriumlaurylsulfoacetat, inkl. kombinationen · ATC A06AG11
9 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Sodium Citrate + Sorbitol + Sodium Lauryl Sulfoacetate
- Manufacturer
- McNeil Sweden AB
- Country
- Norway (NO)
- ATC code
- A06AG11
- ATC class
- Natriumlaurylsulfoacetat, inkl. Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 7
- no_merkevare_idID_FA154D08-2FCB-4CDB-A11E-5999F61E9BA8
- no_varenummer13734950 x 5
- no_varenummer45106912 x 5
- no_varenummer4053134 x 5
- gtin7046261373494
- gtin3574661037851
- gtin3574661037844
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natriumlaurylsulfoacetat, inkl. kombinationen in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMicrolax, KlysmaJNTL Consumer Health II (Switzerland) GmbH
- FinlandMicrolaxMcNeil / JNTL Consumer Health (Finland) Oy
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Microlax
- Estonia · Microlax
- Lithuania · Microlax
- Latvia · Microlax
- Netherlands · Microlax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66f65260-6ed4-4202-99ed-a85e4a8eb58c GET /v1/drugs/66f65260-6ed4-4202-99ed-a85e4a8eb58c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Rektalvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Natriumlaurylsulfoacetat, inkl. kombinasjoner",
"merkevare_id": "ID_FA154D08-2FCB-4CDB-A11E-5999F61E9BA8",
"name_form_strength": "Microlax rektalvæske, oppl 90 mg/ml/9 mg/ml/625 mg/ml",
"prescription_group": "F"
}See everything about natriumlaurylsulfoacetat, inkl. kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.